Correction Notice relating to GBP
5,000,000 Securities due May 2029 (the "Securities") issued
pursuant to the Global Structured Securities Programme Base
Prospectus 16 dated 29 June 2021 (the
"BP16") (ISIN Code: XS2358042807/ Common Code: 235804280)
This Correction Notice relates to
the original final terms for ISIN XS2358042807 dated 23 March 2022 (the
"Original Final Terms"),
which are being replaced by the amended and restated final terms
dated 13 May 2024 (the "Amended
and Restated Final Terms").
The following elements in the
accompanying summary of the Original Final Terms have been amended
in the Amended and Restated Final Terms to correct twelve obvious
inconsistencies with the operative provisions of the Original Final
Terms:
1. In the
What are the main features of the Securities? section of the
Summary, the Currency, denomination, issue size and term of the
Securities is incorrect it has been corrected to match the
operative provisions, such that the relevant expression should
read: 'The Securities will be
denominated in GBP (the "Currency"). The specified denomination per
Security is GBP 1. The issue size is GBP 5,000,000.00 and the issue
price is 100.00% of par. The issue date is 27 May 2022 and the
redemption date is 24 May 2029 (the "Redemption Date"). Such date
may be postponed if the determination of any value used to
calculate an amount payable under the Securities is
delayed.'
2. In the
What are the main features of the Securities? section of the
Summary, the Preference Share Valueinitial
under Final redemption in respect of the
Securities is incorrect it has been corrected to match the
operative provisions, such that the relevant expression should
read: 'the Underlying Preference
Share on 27 May 2022, being the "Initial Valuation Date". The
Initial Valuation Date is subject to adjustment.'
3. In
the What are the main features of the Securities? section of the
Summary, the Initial Price under Final redemption in respect of the
Securities is incorrect it has been corrected to match the
operative provisions, such that the Initial Price should read:
'in respect of an Underlying
Preference Share Reference Asset, the closing price or level of
such Underlying Preference Share Reference Asset on 17 May 2022,
subject to adjustment being 7,518.35.'
4. In the
Summary, the Where will the Securities be traded? is incorrect it
has been corrected to match the operative provisions, such that the
relevant expression should read: 'Application is expected to be made by the
Issuer (or on its behalf) for the Securities to be admitted to
trading on the Regulated Market of the London Stock Exchange with
effect from 27 May 2022.'
5. In the
Key information on the offer of securities to the public and/or the
admission to trading on a regulated market: Under which conditions
and timetable can I invest in these Securities? section of the
Summary the subscription period under the Terms and conditions of
the offer is incorrect and has been corrected to match the
operative provisions, such that the relevant expression should
read: 'The Securities are offered
for subscription in the United Kingdom during the period from (and
including 23 March 2022 to (and including) 19 May 2022 (the "Offer
Period") and such offer is subject to the following
conditions:'
The above corrections do not
affect the Conditions of the Securities in any respect. The rest of
the Original Final Terms remains unchanged.
Capitalised terms used but not
otherwise defined herein shall have the meanings given to them in
the Amended and Restated Final Terms, as read in conjunction with
the GSSP Base Prospectus 16 dated 29 June 2021.
A copy of the Amended and Restated
Final Terms is exhibited at the end of this Correction Notice.
For further information, please
contact
Barclays Bank PLC Registered
Office
1 Churchill Place London E14 5HP
United Kingdom
The date of this notice is 13 May
2024.
DISCLAIMER - INTENDED
ADDRESSEES
IMPORTANT: The following
disclaimer applies to the Amended and Restated Final Terms, and you
are therefore advised to read this disclaimer carefully before
reading, accessing or making any other use of the Amended and
Restated Final Terms, or the Base Prospectus which the Amended and
Restated Final Terms must be read in conjunction with.
NEITHER THE AMENDED AND RESTATED
FINAL TERMS OR BASE PROSPECTUS MAY BE FORWARDED OR DISTRIBUTED
OTHER THAN AS PROVIDED BELOW AND MAY NOT BE REPRODUCED IN ANY
MANNER WHATSOEVER. THE AMENDED AND RESTATED FINAL TERMS AND BASE
PROSPECTUS MAY ONLY BE DISTRIBUTED OUTSIDE THE UNITED STATES TO
PERSONS THAT ARE NOT U.S. PERSONS AS DEFINED IN, AND IN RELIANCE
ON, REGULATION S UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED
(THE "SECURITIES ACT").
FAILURE TO COMPLY WITH THIS NOTICE MAY RESULT IN A VIOLATION OF THE
SECURITIES ACT OR THE APPLICABLE LAWS OF OTHER
JURISDICTIONS.
NOTHING IN THIS ELECTRONIC
PUBLICATION OR IN THE AMENDED AND RESTATED FINAL TERMS AND BASE
PROSPECTUS CONSTITUTES AN OFFER OF THE SECURITIES FOR SALE IN ANY
JURISDICTION WHERE SUCH OFFERS OR SOLICITATIONS ARE NOT PERMITTED
BY LAW. THE SECURITIES HAVE NOT BEEN, AND WILL NOT BE, REGISTERED
UNDER THE SECURITIES ACT OR THE SECURITIES LAWS OF ANY STATE OR
OTHER JURISDICTION OF THE UNITED STATES.
Please note that the information
contained in the Amended and Restated Final Terms and Base
Prospectus may be addressed to and/or targeted at persons who are
residents of particular countries (as specified in the Amended and
Restated Final Terms and Base Prospectus) only and is not intended
for use and should not be relied upon by any person outside these
countries and/or to whom the offer contained in the Amended and
Restated Final Terms and Base Prospectus is not addressed. Prior to
relying on the information contained in the Amended and Restated
Final Terms and Base Prospectus you must ascertain whether or not
you are part of the intended addressees of the information
contained therein.
Confirmation of your Representation:
In order to be eligible to view the Amended and
Restated Final Terms and Base Prospectus or make an investment
decision with respect to the Securities, you must be a person other
than a U.S. person (within the meaning of Regulation S under the
Securities Act) and by accessing the Amended and Restated Final
Terms and Base Prospectus you shall be deemed to have represented
that (i) you and any customers you represent are not U.S. persons
(as defined in Regulation S to the Securities Act) and (ii) you
consent to delivery of the Amended and Restated Final Terms and
Base Prospectus and any amendments or supplements thereto via
electronic transmission.
You are reminded that the Amended
and Restated Final Terms and Base Prospectus have been made
available to you on the basis that you are a person into whose
possession the Amended and Restated Final Terms and Base Prospectus
may be lawfully delivered in accordance with the laws of the jurisdiction in which you are
located and you may not, nor are you authorised to, deliver the
Amended and Restated Final Terms or Base Prospectus, electronically
or otherwise, to any other person.
The Amended and Restated Final
Terms and Base Prospectus have been made available to you in an
electronic form. You are reminded that documents transmitted via
this medium may be altered or changed during the process of
electronic transmission and consequently none of the Issuer, its
advisers nor any person who controls any of them nor any director,
officer, employee nor agent of it or affiliate of any such person
accepts any liability or responsibility whatsoever in respect of
any difference between the Amended and Restated Final Terms and
Base Prospectus made available to you in electronic format and the
hard copy versions available to you on request from the
Issuer.
Amended and Restated Final
Terms
PROHIBITION OF
SALES TO EEA RETAIL INVESTORS - The Securities are not
intended to be offered, sold or otherwise made available to, and
should not be offered, sold or otherwise made available to, any
retail investor in the European Economic Area. For these purposes,
a retail investor means a person who is one (or more) of: (i) a
retail client as defined in point (11) of Article 4(1) of Directive
2014/65/EU (as amended, the "EU
MiFID II"); (ii) a customer within the meaning of Directive
(EU) 2016/97, as amended, where that customer would not qualify as
a professional client as defined in point (10) of Article 4(1) of
the EU MiFID II; or (iii) not a qualified investor as defined in
Regulation (EU) 2017/1129 (as amended, the "EU Prospectus Regulation").
Consequently no key information document required by Regulation
(EU) No 1286/2014 (as amended, the "EU PRIIPs Regulation") for offering or
selling the Securities or otherwise making them available to retail
investors in the European Economic Area has been prepared and
therefore offering or selling the Securities or otherwise making
them available to any retail investor in the European Economic Area
may be unlawful under the EU PRIIPs Regulation.
|
| |
BARCLAYS BANK PLC
(Incorporated with limited
liability in England and Wales)
Legal Entity Identifier (LEI): G5GSEF7VJP5I7OUK5573
GBP 5,000,000 Securities
due May 2029 pursuant to the Global Structured Securities Programme
(the "Tranche 1
Securities")
Issue Price: 100.00 per
cent.
This document constitutes the amended and restatedfinal terms of the Securities (the
"Final Terms" or the "Amended and Restated
Final Terms") described herein for the purposes of
Article 8 of the Regulation (EU)
2017/1129as it forms part of UK domestic law by virtue of
the EuUrnoipoenan (Withdrawal) Act 2018 (as amended) and
regulations made thereunder (as amended, the "UK Prospectus Regulation") and is
prepared in connection with the Global Structured Securities
Programme established by Barclays Bank PLC (the "Issuer"). These Final Terms complete
and should be read in conjunction with GSSP Base Prospectus 16
which constitutes a base prospectus drawn up as
separate documents (including the
Registration Document dated 5 March 2021 as supplemented on 30 July
2021 and 04 November 2021 and the Securities Note relating to the
GSSP Base Prospectus 16 dated 29 June 2021, as supplemented on 18
November 2021) for the purposes of Article 8(6) of the UK
Prospectus Regulation (the "Base
Prospectus"). Full information on the Issuer and the offer
of the Securities is only available on the basis of the combination
of these Final Terms and the Base Prospectus. A summary of the
individual issue of the Securities is annexed to these Final
Terms.
The Base Prospectus, and any supplements thereto, are available for viewing at
https://www.home.barclays/investor-relations/fixed-income-investors/prospectus-and-
documents/structured-securities-prospectusesand
during normal business hours at the registered office of the Issuer
and the specified office of the Issue and Paying Agent for the time
being in London, and copies may be obtained from such office.
Words and expressions defined in the Base Prospectus
and not defined in the Final Terms shall bear the same meanings
when used herein.
BARCLAYS
Amended and Restated Final
Terms dated 13 May 2024 replacing the
original Final
Terms dated 23 March
2022
9. Form of
Securities:
Global Bearer Securities: Permanent Global Security
NGN Form: Not Applicable
Held under the NSS: Not Applicable CGN Form:
Applicable
CDIs: Not Applicable
10.
Trade Date:
18 March 2022
11. 871(m)
Securities
The Issuer has determined that Section 871(m) of the US Internal
Revenue Code is not applicable to the Securities.
12. (i) Prohibition of Sales to UK Retail Investors:
Not Applicable
(ii) Prohibition of Sales to EEA Retail Investors:
Applicable - see the cover page of these Final
Terms
13. Early Cash Settlement
Date:
As specified in General Condition 22.1 (Definitions)
For the purposes of a Preference Share Termination
Event pursuant to General Condition 6 which includes, but is not
limited to, the occurrence of an autocall event in respect of the
Underlying Preference Share, the Securities will be redeemed on the
applicable Early Cash Settlement Date.
The Early Cash Settlement Date(s) corresponding to
the relevant Early Cash Settlement Valuation Date(s) are set out in
the table below:
Early Cash
Settlement Valuation Date(s)
|
Early Cash Settlement
Date(s)
|
17 May
2024
|
24 May
2024
|
19
August 2024
|
27
August 2024
|
18
November
2024
|
25
November
2024
|
17
February 2025
|
24
February 2025
|
19 May
2025
|
27 May
2025
|
18
August 2025
|
26
August 2025
|
17
November
2025
|
24
November
2025
|
17
February 2026
|
24
February 2026
|
18 May
2026
|
26 May
2026
|
17
August 2026
|
24
August 2026
|
17
November
2026
|
24
November
2026
|
17
February 2027
|
24
February 2027
|
17 May
2027
|
24 May
2027
|
17
August 2027
|
24
August 2027
|
17
November
2027
|
24
November
2027
|
17
February 2028
|
24
February 2028
|
17 May
2028
|
24 May
2028
|